Medical management of GI Neuroendocrine tumor

CASE DISCUSSION

Medical management of GI Neuroendocrine tumor

India flagPresented from India by Dr. Mohanad Diab

Case Description

The medical management of gastrointestinal neuroendocrine tumors (GI NETs) involves a comprehensive approach tailored to the specific characteristics of the tumor and the individual patient. For well-differentiated, low-grade tumors that exhibit hormone hypersecretion, somatostatin analogs such as...

Case Summary

  • Cancer was first described in ancient Egypt around 1550 BC, but Hippocrates, around 460 BC, named it "cancer" based on the crab-like appearance he observed during a surgery. For millennia, treatment was limited, often involving alcohol or narcotics for pain relief. The first chemotherapy was only introduced in 1949 in England.

Speaker Profile

Dr. Mohanad Diab

Dr. Mohanad Diab

Consultant Medical Oncologist, Burjeel Hospital, AUH

Disclosures

Assimilate requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. All relevant financial relationships for anyone with the ability to control the content of this educational activity have been reviewed and mitigated. Others involved in the planning of this activity have no relevant financial relationships.
Assimilate | Medical management of GI Neuroendocrine tumor